MCK Mckesson Corporation

  1. Stocks
  2. Healthcare
  3. NYSE: MCK

Price (delayed)

$1,077.08

Market cap

$124.36B

P/E Ratio

27.62

Dividend/share

$3.4

EPS

$38.99

Enterprise value

$128.99B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 36

McKesson Corporation is a diversified healthcare services leader dedicated to advancing health outcomes for patients everywhere. Our teams partner with biopharma companies, care providers, pharmacies, manufacturers, governments, and others to ...

Highlights
The company's EPS rose by 21% YoY and by 4.1% QoQ
MCK's net income is up by 17% YoY and by 2.4% QoQ
MCK's equity has dropped by 127% year-on-year but it is up by 7% since the previous quarter
The debt has grown by 14% year-on-year but it has declined by 4.6% since the previous quarter
The price to earnings (P/E) is 26% more than the last 4 quarters average of 22.0 and 15% more than the 5-year quarterly average of 24.1
Sector: Healthcare
Industry: Medical Distribution
Website: http://www.mckesson.com
Peers: CAH HSIC ACH

Key stats

What are the main financial stats of MCK

MCK stock price

How has the Mckesson stock price performed over time
Intraday
-0.25%
1 week
0.47%
1 month
12.69%
1 year
28.11%
YTD
31.3%
QTD
26.15%

Financial performance

How have Mckesson's revenue and profit performed over time
Revenue
$418.79B
Gross profit
$15.37B
Operating income
$6.69B
Net income
$4.7B
Gross margin
3.7%
Net margin
1.1%
Mckesson's operating income has increased by 27% YoY and by 3% from the previous quarter
MCK's net income is up by 17% YoY and by 2.4% QoQ
Mckesson's operating margin has increased by 14% YoY
The company's gross profit rose by 12% YoY and by 2.8% QoQ

Price vs fundamentals

How does MCK's price correlate with its fundamentals

Growth

What is Mckesson's growth rate over time

Valuation

What is Mckesson stock price valuation
MCK P/E details
P/E
27.62
P/B
N/A
P/S
0.3
EV/EBIT
20.81
EV/EBITDA
17.8
EV/Sales
0.31
The price to earnings (P/E) is 26% more than the last 4 quarters average of 22.0 and 15% more than the 5-year quarterly average of 24.1
The company's EPS rose by 21% YoY and by 4.1% QoQ
MCK's equity has dropped by 127% year-on-year but it is up by 7% since the previous quarter
MCK's P/S is 50% above its 5-year quarterly average of 0.2 and 50% above its last 4 quarters average of 0.2
The revenue is up by 8% year-on-year

Efficiency

How efficient is Mckesson business performance
The return on invested capital rose by 24% year-on-year
The company's return on sales rose by 7% YoY
The return on assets has grown by 3.8% year-on-year

Dividends

What is MCK's dividend history
Dividend details
DPS
$3.4
Dividend yield
0.32%
Payout ratio
8.7%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Mckesson financials performed over time
The total assets is 3.7% smaller than the total liabilities
Mckesson's total liabilities has increased by 12% YoY and by 4% from the previous quarter
The total assets has grown by 10% year-on-year and by 4.5% since the previous quarter
MCK's equity has dropped by 127% year-on-year but it is up by 7% since the previous quarter
Mckesson's debt to equity has increased by 50% YoY but it has decreased by 2.2% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.